期刊文献+

不同材质细胞培养容器培养甲型肝炎病毒的比较 被引量:2

Comparison of culture of hepatitis A virus in vessels of various materials
原文传递
导出
摘要 目的比较中性玻璃转瓶和聚苯乙烯细胞工厂两种材质的培养容器培养人二倍体细胞和甲型肝炎病毒(hepatitis A virus,HAV)的差异。方法采用相同的培养条件,在中性玻璃转瓶和聚苯乙烯细胞工厂中分别培养人胚肺二倍体细胞KMB17,并接种HAV H2株,倒置光学显微镜下观察细胞的形态变化;细胞接种病毒后第0、7、14、18、22、26、30天时取样,ELISA法测定病毒的感染性滴度,分析病毒的增殖动力学。结果两种材质的容器培养的KMB17细胞的生长状态和形态无明显差异;HAV H2株增殖动力学相似;单位体积病毒收获液中的病毒产量无显著差异;聚苯乙烯细胞工厂培养的HAV的单位培养容积产量是中性玻璃转瓶的7.28倍。结论聚苯乙烯细胞工厂和中性玻璃转瓶培养的人二倍体细胞和HAV均能良好生长,细胞工厂可替代转瓶成为新的疫苗规模化生产的细胞培养技术。 Objective To comp are the difference in culture of hepatitis A virus(HAV) in neutral glass spinner and polystyrene cell factory. Methods Human embryonic lung diploid cells(KMB17)were simultaneously cultured in neutral glass spinner and polystyrene cell factory respectively and inoculated with HAV H2 strain,then observed for morphological change under inverted microscope. Samples were taken from the cells on days 0,7,14,18,22,26 and 30 after inoculation and determined for virus titer by ELISA,based on which the kinetics of virus proliferation was analyzed. Results There was no difference in growth states and morphologies of cells cultured in neutral glass spinner and polystyrene cell factory,while the proliferation kinetics were similar. No significant difference was observed between the virus yields per unit volume of the harvests from vessels of two materials. However,the area of KMB17 cells cultured in polystyrene cell factory was 7. 28 times of that in neutral glass spinner. Conclusion Both human diploid cells and HAV grew well in neutral glass spinner and polystyrene cell factory,indicating that cell factory might be used as a novel cell culture technique for large-scale production of vaccine instead of spinner.
出处 《中国生物制品学杂志》 CAS CSCD 2015年第2期190-193,共4页 Chinese Journal of Biologicals
基金 国家十一五"重大新药创制"科技重大专项(2009ZX09504-005) 云南省生物科技重大专项(2012ZA005)
关键词 甲型肝炎病毒 人二倍体细胞 转瓶 细胞工厂 Hepatitis A virus(HAV) Human diploid cells Spinner Cell factory
  • 相关文献

参考文献10

  • 1Cui FQ,Liang XF,Wang FZ,et al.Development,production,and postmarketing surveillance of hepatitis A vaccines in China[J].J Epidemiol,2014,24(3):169-177.
  • 2Cui FQ,Hadler SC,Zheng H,et al.Hepatitis A surveillance and vaccine use in China from 1990 through 2007[J].J Epidemiol,2009,19(4):189-195.
  • 3Mao JS,Dong DX,Zhang HY,et al.Primary study of attenuated live hepatitis A vaccine(H2 strain)in humans[J].J Infect Dis,1989,159(4):621-624.
  • 4郭仁,曹逸云,代振洲,等.人二倍体细胞株KMB-17的特性[J].中国医学科学院学报,1981,3(4):226-230.
  • 5杨净思,曹逸云,王晓辉,胡凝珠,蒋国润,柯华昕,杨晓蕾,王东宝,董德祥.悬浮吸附方法生产H_2株甲肝减毒活疫苗的产量质量及免疫效果[J].中国公共卫生,2001,17(7):584-585. 被引量:3
  • 6Suzuki M,Cela R,Clarke C,et al.Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories[J].Hum Gene Ther,2010,21(1):120-126.
  • 7王红燕,张晋,金歌,佟丁丁,沈莉,郑小滨,柯伟华.细胞工厂在制备口服脊髓灰质炎减毒活疫苗中的应用[J].中国生物制品学杂志,2014,27(4):550-554. 被引量:7
  • 8Reinisch A,Hofmann NA,Obenauf AC,et al.Humanized largescale expanded endothelial colony-forming cells function in vitro and in vivo[J].Blood,2009,113(26):6716-6725.
  • 9刘令九,赵小琳,岳立广,等.细胞工厂培养人胚肺二倍体细胞制备冻干甲型肝炎减毒活疫苗[C].2011中国生物制品年会暨第十一次全国生物制品学术研讨会论文集,四川成都,2011:58-60.
  • 10Bishop NE,Hugo DL,Borovec SV,et al.Rapid and efficient purification of hepatitis A virus from cell culture[J].J Virol Methods,1994,47(1-2):203-216.

二级参考文献9

  • 1郭仁 曹逸云 等.一株二倍体细胞株KMB17的特性[J].中国医学科学院学报,1981,3(1):226-228.
  • 2毛江森 谢汝英 等.甲型肝炎减毒活疫苗的研究1.不同毒力毒株的猴体试验[J].中国科学:B辑,1987,(6):625-630.
  • 3-.中国生物制品规程一部[M].中华人民共和国卫生部,1995.19.
  • 4戴志隆.中国病毒性肝炎血清流行病学调查(上卷),第1版[M].科学技术文献出版社,1997,4.19.
  • 5Hagen A J, Aboud RA, DePhillips PA, et ol. Use of nuclease enzyme in the purification of VAQTA, a hepatitis A vaccine [J]. Biotechnol Appl Biochem, 1996, 23 (Pt 3): 209-215.
  • 6Recommendations to assure the quality, safety and efficacy of live attenuated poliomyelitis vaccine (oral), replacement of TRS 904, Annex 1 and Addendum TRS 910, Annex 1//Expert Committee on Biological Standardization, 63rd meeting, Geneva, 15-19 October 2012 IS]. Geneva: World Health Organization, 2012.
  • 7World Health Organization. Requirements for biological subs- tances No. 7 (Revised 1989) [S]. Geneva: World Health Organi- zation, 1990.
  • 8王斐,单雪峰,戴长河,李倩,赵洪丹,双慧,杨斌,宣黎波,刘志强.水痘减毒活疫苗生产工艺研究[J].中国新药杂志,2012,21(10):1175-1177. 被引量:20
  • 9王亮,杨月莲,周锋,谢蕾,孙世杰,彭晓,周翎乔,马相虎.细胞工厂在水痘疫苗生产中的应用[J].中国新药杂志,2012,21(10):1178-1181. 被引量:17

共引文献8

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部